Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

Brooke Rollins likely has the support to secure Senate confirmation, though members from both political parties raised ...

ExThera Medical has been awarded funding by the Medical Technology Enterprise Consortium (MTEC) to perform a randomized controlled trial to evaluate the efficacy of the Seraph ® 100 Microbind ® ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

The Food and Drug Administration is facing some backlash ... Vivek Ramaswamy have not been shy about about what they plan to target as their agency guides cut under Trump 2.0. Sen.

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

With little competition on the market for Casgevy, a price of $2.2 million in the U.S., increased third-party coverage, and a total target ... the U.S. Food and Drug Administration (FDA) granted ...

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector.

Oklahoma’s 60th regular legislative session begins next week. And while lawmakers have filed more legislation than ever ...